Abstract
Japan is developing a national strategy for biotechnology, which it sees as a transformative technology of strategic importance. Significant institutional transformation has occurred, including changes to the legal structure of universities, partly in an effort to enhance technology transfer. These and other institutional changes are proving conducive to entrepreneurship, and have developed alongside an increase in the number of biotechnology venture firms. This paper presents an overview of these institutional transformations, in the light of recent deregulation and legislative changes. It posits that the emergence of bioventure firms, the increase in their number and, arguably, their changing nature are manifestations of the coevolution of organizations with changes to the institutional framework. Finally, it gives examples of several bioventures, based on interviews conducted with the founders and chief scientists in Japan, and reveals some of the salient characteristics of these firms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
